EN DE
STOCK COMPARISON

Thermo Fisher Scientific vs Abbott Laboratories: Fair Value & Quality

Both stocks run through our valuation models. Here is how Thermo Fisher Scientific (TMO) and Abbott Laboratories (ABT) compare, as of Aug 13, 2026.

As of Aug 13, 2026, Fair Value Calculator sees Abbott Laboratories as the less overvalued of the two: Thermo Fisher Scientific trades at $603 versus a fair value of $308 (-49%), while Abbott Laboratories trades at $111 versus $74.79 (-33%).
Thermo Fisher Scientific
TMO · USD · Health Care
-49%
upside to fair value
overvalued
Price$603
Fair Value$308
Quality63/100
Abbott Laboratories
ABT · USD · Health Care
-33%
upside to fair value
overvalued
Price$111
Fair Value$74.79
Quality67/100

Head-to-head numbers

Green value = the better side for that row (for valuation multiples: lower = cheaper).

Thermo Fisher ScientificAbbott Laboratories
Valuation
29.5×P/E (TTM)27.7×
4.41×P/S (TTM)3.89×
3.74×P/B3.36×
20.0×EV/EBITDA15.1×
1.74×PEG1.47×
0.3%Dividend yield
$1.76Dividend per share
Profitability
15%Net margin14%
18%Operating margin13%
14%Return on equity12%
5%Return on assets6%
Growth
6%Revenue growth (YoY)8%
-0.3%Avg. growth/yr (3Y)0.5%
6.7%Avg. growth/yr (5Y)5.1%
Balance & size
0.67×Debt / equity0.19×
$199BMarket cap$175B
healthyGrowth qualityhealthy

Abbott Laboratories leads: 4 to 9 metric wins.

Dash = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

Thermo Fisher Scientificof which business quality 60 · market factors 69 Abbott Laboratoriesof which business quality 66 · market factors 54
ProfitabilityMargins and returns on capital today
43
50
Quality GrowthAre margins and returns improving?
31
47
CashflowEarnings quality: real cash, not paper profit
62
71
Fin. StrengthBalance sheet, leverage, solvency risk
60
80
InvestmentDisciplined investing over empire-building
79
65
Low VolatilityCalm price path (market factor)
69
83
MomentumPrice trend over the last 3–12 months (market factor)
64
44
52W MomentumDistance to the 52-week high (market factor)
77
36
Net IssuanceBuybacks instead of dilution
97
84

What the models say

The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.

Thermo Fisher Scientific

DCF Models$354
Earnings-Based$203
Multiples$308
Asset-Based$96.29
Growth DCF$288
Economic Profit$159
Growth Earnings$341

24 of 24 models see the stock below the current price.

Abbott Laboratories

DCF Models$73.01
Earnings-Based$29.42
Dividend Discount$39.73
Multiples$70.72
Asset-Based$20.05
Growth DCF$67.02
Economic Profit$37.49
Growth Earnings$70.25

26 of 26 models see the stock below the current price.

Scenario ranges

From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.

Thermo Fisher Scientific
Bear $171Fair Value $308Bull $385
$603 = current price (white tick)
Abbott Laboratories
Bear $51.13Fair Value $74.79Bull $94.43
$111 = current price (white tick)

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

Thermo Fisher Scientific · Health Care

Quality score63 · Top 25%
Fair value upside-49% · below median

Abbott Laboratories · Health Care

Quality score67 · Top 25%
Fair value upside-33% · below median

Bottom line

As of Aug 13, 2026, Fair Value Calculator sees Abbott Laboratories as the less overvalued of the two: Thermo Fisher Scientific trades at $603 versus a fair value of $308 (-49%), while Abbott Laboratories trades at $111 versus $74.79 (-33%).

Abbott Laboratories has the higher quality score (67/100).

See the full analysis →

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.